nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—PDGFRA—penis—penile cancer	0.052	0.062	CbGeAlD
Dasatinib—BMX—skin of body—penile cancer	0.0213	0.0254	CbGeAlD
Dasatinib—BMX—urethra—penile cancer	0.0204	0.0243	CbGeAlD
Dasatinib—PTK6—skin of body—penile cancer	0.02	0.0238	CbGeAlD
Dasatinib—PTK6—urethra—penile cancer	0.0191	0.0228	CbGeAlD
Dasatinib—STAT5B—skin of body—penile cancer	0.0189	0.0225	CbGeAlD
Dasatinib—STAT5B—urethra—penile cancer	0.0181	0.0215	CbGeAlD
Dasatinib—ZAK—urethra—penile cancer	0.0151	0.018	CbGeAlD
Dasatinib—TEC—lymph node—penile cancer	0.0148	0.0176	CbGeAlD
Dasatinib—EPHB2—L1CAM interactions—SCN10A—penile cancer	0.0141	0.0876	CbGpPWpGaD
Dasatinib—TESK1—urethra—penile cancer	0.0134	0.0159	CbGeAlD
Dasatinib—STK36—urethra—penile cancer	0.0131	0.0157	CbGeAlD
Dasatinib—EPHB3—urethra—penile cancer	0.0131	0.0157	CbGeAlD
Dasatinib—STK35—skin of body—penile cancer	0.0129	0.0153	CbGeAlD
Dasatinib—CSK—skin of body—penile cancer	0.0128	0.0152	CbGeAlD
Dasatinib—CSK—urethra—penile cancer	0.0122	0.0146	CbGeAlD
Dasatinib—HCK—urethra—penile cancer	0.0121	0.0144	CbGeAlD
Dasatinib—RIPK2—skin of body—penile cancer	0.0119	0.0141	CbGeAlD
Dasatinib—EPHB1—lymph node—penile cancer	0.0116	0.0138	CbGeAlD
Dasatinib—SIK1—skin of body—penile cancer	0.0116	0.0138	CbGeAlD
Dasatinib—RIPK2—urethra—penile cancer	0.0114	0.0135	CbGeAlD
Dasatinib—ERBB3—skin of body—penile cancer	0.0113	0.0135	CbGeAlD
Dasatinib—SIK1—urethra—penile cancer	0.0111	0.0132	CbGeAlD
Dasatinib—EPHA4—urethra—penile cancer	0.011	0.0131	CbGeAlD
Dasatinib—MAPK14—skin of body—penile cancer	0.0106	0.0126	CbGeAlD
Dasatinib—FGR—urethra—penile cancer	0.0101	0.012	CbGeAlD
Dasatinib—LCK—urethra—penile cancer	0.0101	0.012	CbGeAlD
Dasatinib—JAK2—skin of body—penile cancer	0.00995	0.0119	CbGeAlD
Dasatinib—FYN—skin of body—penile cancer	0.00981	0.0117	CbGeAlD
Dasatinib—BMX—lymph node—penile cancer	0.00973	0.0116	CbGeAlD
Dasatinib—BLK—lymph node—penile cancer	0.00962	0.0115	CbGeAlD
Dasatinib—EPHB4—urethra—penile cancer	0.0096	0.0114	CbGeAlD
Dasatinib—MAP3K3—skin of body—penile cancer	0.00959	0.0114	CbGeAlD
Dasatinib—EPHB1—Axon guidance—SCN10A—penile cancer	0.00958	0.0595	CbGpPWpGaD
Dasatinib—JAK2—urethra—penile cancer	0.00953	0.0114	CbGeAlD
Dasatinib—EPHA2—urethra—penile cancer	0.00941	0.0112	CbGeAlD
Dasatinib—FYN—urethra—penile cancer	0.0094	0.0112	CbGeAlD
Dasatinib—TXK—lymph node—penile cancer	0.00921	0.011	CbGeAlD
Dasatinib—MAP4K5—urethra—penile cancer	0.00918	0.0109	CbGeAlD
Dasatinib—MAP3K3—urethra—penile cancer	0.00918	0.0109	CbGeAlD
Dasatinib—EPHB6—skin of body—penile cancer	0.00916	0.0109	CbGeAlD
Dasatinib—EPHB6—urethra—penile cancer	0.00878	0.0105	CbGeAlD
Dasatinib—STAT5B—lymph node—penile cancer	0.00862	0.0103	CbGeAlD
Dasatinib—SRC—skin of body—penile cancer	0.00852	0.0102	CbGeAlD
Dasatinib—YES1—urethra—penile cancer	0.00848	0.0101	CbGeAlD
Dasatinib—EPHA3—lymph node—penile cancer	0.00797	0.0095	CbGeAlD
Dasatinib—SIK3—lymph node—penile cancer	0.00775	0.00924	CbGeAlD
Dasatinib—CSF1R—skin of body—penile cancer	0.00765	0.00911	CbGeAlD
Dasatinib—MAP2K5—urethra—penile cancer	0.00751	0.00895	CbGeAlD
Dasatinib—CSF1R—urethra—penile cancer	0.00732	0.00873	CbGeAlD
Dasatinib—ZAK—lymph node—penile cancer	0.00721	0.00859	CbGeAlD
Dasatinib—KIT—skin of body—penile cancer	0.00694	0.00828	CbGeAlD
Dasatinib—BMPR1B—lymph node—penile cancer	0.00691	0.00824	CbGeAlD
Dasatinib—BTK—lymph node—penile cancer	0.00687	0.00819	CbGeAlD
Dasatinib—EPHB1—Developmental Biology—SCN10A—penile cancer	0.00684	0.0424	CbGpPWpGaD
Dasatinib—PDGFRB—skin of body—penile cancer	0.00678	0.00808	CbGeAlD
Dasatinib—TNK2—lymph node—penile cancer	0.00678	0.00808	CbGeAlD
Dasatinib—KIT—urethra—penile cancer	0.00665	0.00793	CbGeAlD
Dasatinib—PDGFRB—urethra—penile cancer	0.0065	0.00774	CbGeAlD
Dasatinib—EPHB3—Axon guidance—SCN10A—penile cancer	0.00647	0.0402	CbGpPWpGaD
Dasatinib—TESK1—lymph node—penile cancer	0.00637	0.00759	CbGeAlD
Dasatinib—STK36—lymph node—penile cancer	0.00627	0.00747	CbGeAlD
Dasatinib—EPHB3—lymph node—penile cancer	0.00627	0.00747	CbGeAlD
Dasatinib—LIMK2—lymph node—penile cancer	0.00606	0.00722	CbGeAlD
Dasatinib—ABL1—skin of body—penile cancer	0.00604	0.0072	CbGeAlD
Dasatinib—STK35—lymph node—penile cancer	0.00587	0.007	CbGeAlD
Dasatinib—CSK—lymph node—penile cancer	0.00584	0.00696	CbGeAlD
Dasatinib—ABL1—urethra—penile cancer	0.00579	0.0069	CbGeAlD
Dasatinib—EPHA5—Axon guidance—SCN10A—penile cancer	0.00577	0.0358	CbGpPWpGaD
Dasatinib—ABL2—Axon guidance—SCN10A—penile cancer	0.00577	0.0358	CbGpPWpGaD
Dasatinib—EPHA3—Axon guidance—SCN10A—penile cancer	0.00577	0.0358	CbGpPWpGaD
Dasatinib—HCK—lymph node—penile cancer	0.00576	0.00687	CbGeAlD
Dasatinib—ABL2—lymph node—penile cancer	0.00572	0.00682	CbGeAlD
Dasatinib—EPHA8—Axon guidance—SCN10A—penile cancer	0.00556	0.0346	CbGpPWpGaD
Dasatinib—EPHA4—Axon guidance—SCN10A—penile cancer	0.0055	0.0342	CbGpPWpGaD
Dasatinib—LIMK2—Axon guidance—SCN10A—penile cancer	0.0055	0.0342	CbGpPWpGaD
Dasatinib—EPHB4—Axon guidance—SCN10A—penile cancer	0.0055	0.0342	CbGpPWpGaD
Dasatinib—RIPK2—lymph node—penile cancer	0.00542	0.00646	CbGeAlD
Dasatinib—EPHB2—Axon guidance—SCN10A—penile cancer	0.00533	0.0331	CbGpPWpGaD
Dasatinib—SIK1—lymph node—penile cancer	0.00529	0.0063	CbGeAlD
Dasatinib—EPHA4—lymph node—penile cancer	0.00524	0.00624	CbGeAlD
Dasatinib—ERBB3—lymph node—penile cancer	0.00518	0.00618	CbGeAlD
Dasatinib—EPHB6—Axon guidance—SCN10A—penile cancer	0.00517	0.0321	CbGpPWpGaD
Dasatinib—MAP3K2—lymph node—penile cancer	0.00513	0.00612	CbGeAlD
Dasatinib—CYP1B1—skin of body—penile cancer	0.00512	0.0061	CbGeAlD
Dasatinib—MAPK14—lymph node—penile cancer	0.00483	0.00575	CbGeAlD
Dasatinib—FGR—lymph node—penile cancer	0.00481	0.00573	CbGeAlD
Dasatinib—LCK—lymph node—penile cancer	0.00481	0.00573	CbGeAlD
Dasatinib—FMO3—lymph node—penile cancer	0.00464	0.00554	CbGeAlD
Dasatinib—EPHB3—Developmental Biology—SCN10A—penile cancer	0.00462	0.0287	CbGpPWpGaD
Dasatinib—EPHB4—lymph node—penile cancer	0.00458	0.00546	CbGeAlD
Dasatinib—JAK2—lymph node—penile cancer	0.00454	0.00542	CbGeAlD
Dasatinib—EPHA2—lymph node—penile cancer	0.00449	0.00535	CbGeAlD
Dasatinib—EPHA2—Axon guidance—SCN10A—penile cancer	0.00449	0.0278	CbGpPWpGaD
Dasatinib—FYN—lymph node—penile cancer	0.00448	0.00534	CbGeAlD
Dasatinib—MAP3K3—lymph node—penile cancer	0.00438	0.00522	CbGeAlD
Dasatinib—MAP4K5—lymph node—penile cancer	0.00438	0.00522	CbGeAlD
Dasatinib—EPHB6—lymph node—penile cancer	0.00419	0.00499	CbGeAlD
Dasatinib—EPHA3—Developmental Biology—SCN10A—penile cancer	0.00412	0.0256	CbGpPWpGaD
Dasatinib—ABL2—Developmental Biology—SCN10A—penile cancer	0.00412	0.0256	CbGpPWpGaD
Dasatinib—EPHA5—Developmental Biology—SCN10A—penile cancer	0.00412	0.0256	CbGpPWpGaD
Dasatinib—YES1—lymph node—penile cancer	0.00404	0.00482	CbGeAlD
Dasatinib—EPHA8—Developmental Biology—SCN10A—penile cancer	0.00397	0.0247	CbGpPWpGaD
Dasatinib—PDGFRA—lymph node—penile cancer	0.00397	0.00473	CbGeAlD
Dasatinib—SRC—L1CAM interactions—SCN10A—penile cancer	0.00393	0.0244	CbGpPWpGaD
Dasatinib—LIMK2—Developmental Biology—SCN10A—penile cancer	0.00393	0.0244	CbGpPWpGaD
Dasatinib—EPHA4—Developmental Biology—SCN10A—penile cancer	0.00393	0.0244	CbGpPWpGaD
Dasatinib—EPHB4—Developmental Biology—SCN10A—penile cancer	0.00393	0.0244	CbGpPWpGaD
Dasatinib—SRC—lymph node—penile cancer	0.00389	0.00464	CbGeAlD
Dasatinib—EPHB2—Developmental Biology—SCN10A—penile cancer	0.0038	0.0236	CbGpPWpGaD
Dasatinib—EPHB6—Developmental Biology—SCN10A—penile cancer	0.00369	0.0229	CbGpPWpGaD
Dasatinib—ABCG2—urethra—penile cancer	0.00365	0.00435	CbGeAlD
Dasatinib—CYP1A1—skin of body—penile cancer	0.00362	0.00431	CbGeAlD
Dasatinib—MAP2K5—lymph node—penile cancer	0.00358	0.00427	CbGeAlD
Dasatinib—CSF1R—lymph node—penile cancer	0.00349	0.00416	CbGeAlD
Dasatinib—CYP1A1—urethra—penile cancer	0.00347	0.00413	CbGeAlD
Dasatinib—EPHA2—Developmental Biology—SCN10A—penile cancer	0.0032	0.0199	CbGpPWpGaD
Dasatinib—KIT—lymph node—penile cancer	0.00317	0.00378	CbGeAlD
Dasatinib—PDGFRB—lymph node—penile cancer	0.0031	0.00369	CbGeAlD
Dasatinib—ABL1—lymph node—penile cancer	0.00276	0.00329	CbGeAlD
Dasatinib—YES1—Axon guidance—SCN10A—penile cancer	0.00274	0.017	CbGpPWpGaD
Dasatinib—CYP1B1—lymph node—penile cancer	0.00234	0.00279	CbGeAlD
Dasatinib—LYN—Axon guidance—SCN10A—penile cancer	0.00205	0.0127	CbGpPWpGaD
Dasatinib—ABL1—Axon guidance—SCN10A—penile cancer	0.00204	0.0126	CbGpPWpGaD
Dasatinib—FYN—Axon guidance—SCN10A—penile cancer	0.00201	0.0125	CbGpPWpGaD
Dasatinib—YES1—Developmental Biology—SCN10A—penile cancer	0.00196	0.0122	CbGpPWpGaD
Dasatinib—JAK2—Axon guidance—SCN10A—penile cancer	0.00191	0.0119	CbGpPWpGaD
Dasatinib—ABCB1—urethra—penile cancer	0.0018	0.00215	CbGeAlD
Dasatinib—ABCG2—lymph node—penile cancer	0.00174	0.00208	CbGeAlD
Dasatinib—CYP1A1—lymph node—penile cancer	0.00165	0.00197	CbGeAlD
Dasatinib—SRC—Axon guidance—SCN10A—penile cancer	0.00148	0.00922	CbGpPWpGaD
Dasatinib—LYN—Developmental Biology—SCN10A—penile cancer	0.00146	0.00907	CbGpPWpGaD
Dasatinib—ABL1—Developmental Biology—SCN10A—penile cancer	0.00145	0.00902	CbGpPWpGaD
Dasatinib—FYN—Developmental Biology—SCN10A—penile cancer	0.00144	0.00892	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—SCN10A—penile cancer	0.00138	0.00859	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—SCN10A—penile cancer	0.00137	0.00848	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—SCN10A—penile cancer	0.00106	0.00658	CbGpPWpGaD
Dasatinib—ABCB1—lymph node—penile cancer	0.000859	0.00102	CbGeAlD
